Table 1.
– Characteristics of the study population (mean ± SD).
| Variable | Men (n = 3103) | Women (n = 2447) | P value |
|---|---|---|---|
| Age (yr) | 49.0 ± 11.9 | 50.0 ± 12.8 | .005 |
| BMI (kg/m2) | 24.6 ± 3.3 | 23.5 ± 3.8 | |
| WC (cm) | 87.6 ± 8.7 | 80.7 ± 10.2 | < .0001 |
| SBP (mmHg) | 125.5 ± 16.4 | 118.7 ± 19.8 | < .0001 |
| DB (mmHg) | 80.1 ± 10.5 | 74.9 ± 10.8 | < .0001 |
| ALT (IU/l) | 35.5 ± 44.5 | 24.0 ± 21.5 | < .0001 |
| Fasting glucose (mg/dl) | 104.0 ± 34.2 | 100.5 ± 29.3 | .0001 |
| TC (mg/dl) | 201.8 ± 39.4 | 199.1 ± 39.3 | .01 |
| TG (mg/dl) | 134.4 ± 136.2 | 97.6 ± 73.1 | < .0001 |
| LDL (mg/dl) | 129.1 ± 34.7 | 122.8 ± 35.0 | < .0001 |
| HDL (mg/dl) | 43.4 ± 11.0 | 52.4 ± 13.2 | < .0001 |
| Uric acid (mg/dl) | 6.7 ± 1.4 | 5.4 ± 1.3 | < .0001 |
| Elevated ALT (%) | 721 (23.2) | 229 (9.4) | < .0001 |
| HBsAg (+) (%) | 538 (17.3) | 286 (11.7) | < .0001 |
| Anti-HCV (+) (%) | 138 (4.4) | 138 (5.6) | .042 |
| Fatty liver (%) | 1639 (52.8) | 897 (36.7) | < .0001 |
| Gall stone (%) | 158 (5.1) | 138 (5.6) | .367 |
| Cirrhosis (%) | 19 (0.6) | 7 (0.3) | .077 |
| Hepatocellular carcinoma (%) | 7 (0.2) | 1 (0.004) | .072 |
| Smoker (%) | 1280 (41.3) | 146 (6.0) | < .0001 |
| Drinker (%) | 536 (17.3) | 70 (2.9) | < .0001 |